#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Glioblastoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Glioblastoma multiforme Acute promyelocytic leukaemia Follicle centre lymphoma follicular grade I, II – III Plasma cell myeloma recurrent Malignant neoplasm of choroid Congenital ectodermal dysplasia Guillain-Barre syndrome Crohn's disease Cerebral amyloid angiopathy Deafness bilateral Selective polysaccharide antibody deficiency Pituitary-dependent Cushing's syndrome More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome Familial amyotrophic lateral sclerosis – Basic Information Choroid melanoma – Life with Disease Pelizaeus-Merzbacher disease – Basic Information Alternating hemiplegia of childhood – Life with Disease Testicular leiomyosarcoma Proteus syndrome – Treatment Familial haemophagocytic lymphohistiocytosis – Life with Disease Breast angiosarcoma – Basic Information Netherton’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GRAPHITE TRIMIPRAMINE MALEATE Acetylsalicylic Acid Cd7-Cart01 68Ganota-Anti-Her2 Vhh1 99MTC-EUK-(SO3)CY5-MAS3 SOFOSBUVIR Metamizole Magnesium Anhydrous Docetaxel Ondansetron Posenacaftor 18F-Fludarabine Idarubicin Hydrochloride Abc-24F-116 Belatacept Golexanolone Rifabutin Tofersen Gt005 Propafenone Hydrochloride More therapies…

    Learn about Your Condition

    HER2 negative breast cancer Laryngeal cancer Rhabdoid tumour Polycythaemia vera Hairy cell leukaemia Renal cancer Periarthritis Conjunctivitis allergic Meningorrhagia Organ donor Lyme disease Weaning failure Peritoneal dialysis Encephalopathy neonatal Angiosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of denikitug alone or with drug combination in adults with HER2‑negative metastatic gastric, gastroesophageal junction and esophageal adenocarcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Ramucirumab
    • Nivolumab
    • Paclitaxel Albumin-Bound
    France Spain

  • Long‑term safety study of S68587 (allogeneic CD19 CAR T‑cells with TRAC and CD52 disruption) in patients with advanced lymphoid leukemia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    France

  • Efficacy of colistimethate sodium and ciprofloxacin for eradicating primary Pseudomonas aeruginosa infection in adults with bronchiectasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Colistimethate Sodium
    • Ciprofloxacin
    • Sodium Chloride
    Spain

  • Phase 1/2 Study of VS-7375 with Drug Combination in Patients with Advanced KRAS G12D‑Mutated Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cetuximab
    • Gemcitabine
    Belgium France Germany Italy The Netherlands Spain

  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Spain

  • Efficacy of sufentanil versus fentanyl for postoperative pain in patients undergoing urgent laparoscopic cholecystectomy

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Fentanyl
    • Sufentanil
    Spain
Previous Page
1 … 696 697 698 699 700 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!